ARCHIVES

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

This article is from The Cancer Letter archive.

Vol. 09 No. 30 | July 29, 1983

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

FDA Approves NDA for Sodium Fluoride F18

February 4, 2011

NCAB Approves New Pancreatic Cancer Project, Hears Favorable Reports On Organ site Programs

November 29, 1974

NCI Cooperative Group, Cancer Center Trials Listed

January 30, 2009